| AMVRX | VMVAX | AMVRX / VMVAX | |
| Total Expense Ratio | 1.47 | 0.07 | 2,100% |
| Annual Report Gross Expense Ratio | 1.47 | 0.07 | 2,100% |
| Fund Existence | 20 years | 14 years | - |
| Gain YTD | 6.660 | 6.937 | 96% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000 | 83% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.44B | 31.8B | 20% |
| Annual Yield % from dividends | 1.04 | 2.20 | 47% |
| Returns for 1 year | -6.51 | -1.53 | 426% |
| Returns for 3 years | 0.43 | 22.90 | 2% |
| Returns for 5 years | 1.96 | 48.47 | 4% |
| Returns for 10 years | 8.30 | 97.67 | 8% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VSENX | 52.80 | 1.31 | +2.54% |
| JPMorgan Small Cap Equity R6 | |||
| GTCSX | 31.77 | 0.72 | +2.32% |
| Glenmede Small Cap Equity Adv | |||
| DFCEX | 28.43 | 0.14 | +0.49% |
| DFA Emerging Markets Core Equity 2 I | |||
| WELIX | 11.41 | 0.05 | +0.44% |
| William Blair Emerging Mkts Ldrs R6 | |||
| HSGFX | 5.86 | N/A | N/A |
| Hussman Strategic Market Cycle Fund | |||